A current practice for predicting ocular toxicity of systemically delivered drugs

References

• Moorthy RS, Valluri S. Ocular toxicity associated with systemic drug therapy. Curr Opin Ophthalmol 1999; 10(6):438–446.
   PubMedGoogle Scholar
• Fraunfelder FW. Ocular adverse drug reactions. Expert Opin Drug Saf 2003; 2(4):411–420.
   PubMedGoogle Scholar
• Santaella RM, Fraunfelder FW. Ocular adverse effects associated with systemic medications: recognition and management. Drugs 2007; 67(1):75–93.
   PubMed Web of Science ®Google Scholar
• Fraunfelder FW, ed. Drug-Induced Ocular Side Effects. 5th ed; Oxford, UK: Butterworth-Heinemann. 2001.
   Google Scholar
• Brick DC. Medication errors result in costly claims for ophthalmologists. Surv Ophthalmol 1995; 40(3):232–236.
   PubMed Web of Science ®Google Scholar
• Smith CG, O’Donnell JT, eds. The Process of New Drug Discovery and Development. 2 ed; New York: Informa Healthcare. 2006.
   Google Scholar
• Illanes O, Anderson S, Niesman M, Zwick L, Jessen BA. Retinal and peripheral nerve toxicity induced by the administration of a pan-cyclin dependent kinase (cdk) inhibitor in mice. Toxicol Pathol 2006; 34(3):243–248.
   PubMed Web of Science ®Google Scholar
• Matfield M. Animal experimentation: the continuing debate. Nat Rev Drug Discov 2002; 1(2):149–152.
   PubMed Web of Science ®Google Scholar
• Kramer JA, Sagartz JE, Morris DL. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates. Nat Rev Drug Discov 2007; 6(8):636–649.
   PubMed Web of Science ®Google Scholar
• Cunha-Vaz JG. The blood-ocular barriers: past, present, and future. Doc Ophthalmol 1997; 93(1–2):149–157.
   PubMed Web of Science ®Google Scholar
• Hornof M, Toropainen E, Urtti A. Cell culture models of the ocular barriers. Eur J Pharm Biopharm 2005; 60(2):207–225.
   PubMed Web of Science ®Google Scholar
• Davila JC, Rodriguez RJ, Melchert RB, Acosta D. Predictive value of in vitro model systems in toxicology. Annu Rev Pharmacol Toxicol 1998; 38(1):63–96.
   PubMedGoogle Scholar
• Kruszewski F. Human cells as in vitro alternatives for ocular toxicity studies. Comments Toxicol 1998; 6(3):221–233.
   Google Scholar
• Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391(6669):806–811.
   PubMed Web of Science ®Google Scholar
• Peiffer RL, McCary B, Bee W, Wegener A, Geller AM, Boyes WK. Contemporary methods in ocular toxicology. Toxicol Mech Methods 2000; 10(1):17–39.
   Google Scholar
• Loging W, Harland L, Williams-Jones B. High-throughput electronic biology: mining information for drug discovery. Nat Rev Drug Discov 2007; 6(3):220–230.
   PubMed Web of Science ®Google Scholar
• Pollard J, Butte AJ, Hoberman S, Joshi M, Levy J, Pappo J. A computational model to define the molecular causes of type 2 diabetes mellitus. Diabetes Technol Ther 2005; 7(2):323–336.
   PubMedGoogle Scholar
• Musante CJ, Lewis AK, Hall K. Small- and large-scale biosimulation applied to drug discovery and development. Drug Discov Today 2002; 7(20 suppl):S192–S196.
   PubMed Web of Science ®Google Scholar
• Taylor JB, Triggle DJ. eds. Comprehensive Medicinal II; New York: Elsevier Science. 2006.
   Google Scholar
• Greene N. Computational models to predict toxicity. In: Triggle DJ. ed. Comprehensive Medicinal Chemistry II. 1 ed; Oxford: Elsevier Ltd. 2007:909–932.
   Google Scholar
• Hale R. Text mining: getting more value from literature resources. Drug Discov Today 2005; 10(6):337–379.
   Google Scholar
• Elliston K. Breaking through the cognitive barriers that impede critical path research. Am Biotechnol Lab 2004; 22(12):28–30.
   Google Scholar
• Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 2006; 58(3):488–520.
   PubMed Web of Science ®Google Scholar
• Lugnier C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 2006; 109(3):366–398.
   PubMed Web of Science ®Google Scholar
• Chabre M, Deterre P. Molecular mechanism of visual transduction. Eur J Biochem 1989; 179(2):255–266.
   PubMedGoogle Scholar
• Yarfitz S, Hurley JB. Transduction mechanisms of vertebrate and invertebrate photoreceptors. J Biol Chem 1994; 269(20):14329–14332.
   PubMed Web of Science ®Google Scholar
• Lolley RN, Farber DB, Rayborn ME, Hollyfield JG. Cyclic GMP accumulation causes degeneration of photoreceptor cells: simulation of an inherited disease. Science 1977; 196(4290):664–666.
   PubMed Web of Science ®Google Scholar
• Kameni Tcheudji JF, Lebeau L, Virmaux N, Maftei CG, Cote RH, Lugnier C, Schultz P. Molecular organization of bovine rod cGMP-phosphodiesterase 6. J Mol Biol 2001; 310(4):781–791.
   PubMed Web of Science ®Google Scholar
• Cote RH. Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5. Int J Impot Res 2004; 16(suppl 1):S28–S33.
   PubMed Web of Science ®Google Scholar
• Marmor MF, Kessler R. Sildenafil (Viagra) and ophthalmology. Surv Ophthalmol 1999; 44(2):153–162.
   PubMed Web of Science ®Google Scholar
• Muster W, Breidenbach A, Fischer H, Kirchner S, Muller L, Pahler A. Computational toxicology in drug development. Drug Discov Today 2008; 13(7–8):303–310.
   PubMed Web of Science ®Google Scholar
• Egan WJ, Zlokarnik G, Grootenhuis PDJ. In silico prediction of drug safety: despite progress there is abundant room for improvement. Drug Discov Today Technol 2004; 1(4):381–387.
   PubMedGoogle Scholar
• Chen YZ, Yap CW, Li H. Current QSAR techniques for toxicology. In: Ekins, S. ed. Computational Toxicology: Risk Assessment for Pharmaceutical and Environmental Chemicals. New York: John Wiley & Sons. 2007:217–238.
   Google Scholar
• Ridings JE, Barratt MD, Cary R, Earnshaw CG, Eggington CE, Ellis MK, Judson PN, Langowski JJ, Marchant CA, Payne MP, Watson WP, Yih TD. Computer prediction of possible toxic action from chemical structure: an update on the DEREK system. Toxicology 1996; 106(1–3):267–279.
   PubMed Web of Science ®Google Scholar
• Greene N, Judson PN, Langowski JJ, Marchant CA. Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. SAR QSAR Environ Res 1999; 10(2–3):299–314.
   PubMed Web of Science ®Google Scholar
• Greene N. Computer systems for the prediction of toxicity: an update. Adv Drug Deliv Rev 2002; 54(3):417–431.
   PubMed Web of Science ®Google Scholar
• Hobbs HE, Sorsby A, Freedman A. Retinopathy following chloroquine therapy. Lancet 1959; 2(7101):478–480.
   PubMedGoogle Scholar
• Maguire A. Amodiaquine hydrochloride. Corneal deposits and pigmented palate and nails after treatment of chronic discoid lupus erythematosus. Lancet 1962; 1(7231)667.
   PubMedGoogle Scholar
• Isaac NE, Walker AM, Jick H, Gorman M. Exposure to phenothiazine drugs and risk of cataract. Arch Ophthalmol 1991; 109(2):256–260.
   PubMed Web of Science ®Google Scholar
• Subashini K, Rao VA. Chlorpromazine-induced cataract and corneal pigmentation. Indian J Pharmacol 2004; 36(5):323–324.
   Google Scholar
• Jaanus SD. Ocular side effects of selected systemic drugs. Optom Clin 1992; 2(4):73–96.
   PubMedGoogle Scholar
• Power WJ, Travers SP, Mooney DJ. Welding arc maculopathy and fluphenazine. Br J Ophthalmol 1991; 75(7):433–435.
   PubMed Web of Science ®Google Scholar
• Ubels JL, Clousing DP. In vitro alternatives to the use of animals in ocular toxicology testing. Ocul Surf 2005; 3(3):126–142.
   PubMed Web of Science ®Google Scholar
• EMEA Report. Note for guidance on photosafety testing. CPMP/SWP/398/01. 2002. http://www.emea.europa.eu/pdfs/human/swp/039801en.pdf accessed June 27, 2002..
   Google Scholar
• Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985; 24(2–3):119–124.
   PubMed Web of Science ®Google Scholar
• Nilsson R, Maurer T, Redmond N. A standard protocol for phototoxicity testing. Results from an interlaboratory study. Contact Dermatitis 1993; 28(5):285–290.
   PubMed Web of Science ®Google Scholar
• Spielmann H, Balls M, Dupuis J, Pape WJ, Pechovitch G, Silva Od, Holzhuetter HG, Clothier R, Desolle P, Gerberick F, Liebsch M, Lovell WW, Maurer T, Pfannenbecker U, Potthast JM, Csato M, Sladowski D, Steiling W, Brantom P. The International EU/COLIPA In Vitro Phototoxicity Validation Study: results of phase II (blind trial). Part 1: the 3T3 NRU phototoxicity test. Toxicol In Vitro 1998; 12(3):305–327.
   PubMed Web of Science ®Google Scholar
• Peters B, Holzhutter HG. In vitro phototoxicity testing: development and validation of a new concentration response analysis software and biostatistical analyses related to the use of various prediction models. Altern Lab Anim 2002; 30(4):415–432.
   PubMed Web of Science ®Google Scholar
• Spielmann H, Muller L, Averbeck D, Balls M, Brendler-Schwaab S, Castell JV, Curren R, de Silva O, Gibbs NK, Liebsch M, Lovell WW, Merk HF, Nash JF, Neumann NJ, Pape WJ, Ulrich P, Vohr HW. The second ECVAM workshop on phototoxicity testing. The report and recommendations of ECVAM workshop 42. Altern Lab Anim 2000; 28(6):777–814.
   PubMed Web of Science ®Google Scholar
• Epstein JH, Wintroub BU. Photosensitivity due to drugs. Drugs 1985; 30(1):42–57.
   PubMed Web of Science ®Google Scholar
• Epstein JH. Phototoxicity and photoallergy. Semin Cutan Med Surg 1999; 18(4):274–284.
   PubMed Web of Science ®Google Scholar
• Onoue S, Tsuda Y. Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances. Pharm Res 2006; 23(1):156–164.
   PubMed Web of Science ®Google Scholar
• Onoue S, Kawamura K, Igarashi N, Zhou Y, Fujikawa M, Yamada H, Tsuda Y, Seto Y, Yamada S. Reactive oxygen species assay-based risk assessment of drug-induced phototoxicity: classification criteria and application to drug candidates. J Pharm Biomed Anal 2008; 47(4–5):967–972.
   PubMed Web of Science ®Google Scholar
• Lynch AM, Robinson SA, Wilcox P, Smith MD, Kleinman M, Jiang K, Rees RW. Cycloheximide and disulfoton are positive in the photoclastogencity assay but do not absorb UV irradiation: another example of pseudophotoclastogenicity? Mutagenesis 2008; 23(2):111–118.
   PubMed Web of Science ®Google Scholar
• Aleo MD, Avery MJ, Beierschmitt WP, Drupa CA, Fortner JH, Kaplan AH, Navetta KA, Shepard RM, Walsh CM. The use of explant lens culture to assess cataractogenic potential. Ann N Y Acad Sci 2000; 919: 71–187.
   Google Scholar
• Aleo MD, Doshna CM, Navetta KA. Ciglitazone-induced lenticular opacities in rats: in vivo and whole lens explant culture evaluation. J Pharmacol Exp Ther 2005; 312(3):1027–1033.
   PubMed Web of Science ®Google Scholar
• Walsh Clang CM, Aleo MD. Mechanistic analysis of S-(1,2-dichlorovinyl)-L-cysteine-induced cataractogenesis in vitro. Toxicol Appl Pharmacol 1997; 146(1):144–155.
   PubMed Web of Science ®Google Scholar
• Pauls E, Este JA. RNA interference as a tool for target validation. Drug Discov Today Technol 2004; 1(2):135–140.
   PubMedGoogle Scholar
• Choudhary S, Xiao T, Vergara LA, Srivastava S, Nees D, Piatigorsky J, Ansari NH. Role of aldehyde dehydrogenase isozymes in the defense of rat lens and human lens epithelial cells against oxidative stress. Invest Ophthalmol Vis Sci 2005; 46(1):259–267.
   PubMed Web of Science ®Google Scholar
• Lassen N, Bateman JB, Estey T, Kuszak JR, Nees DW, Piatigorsky J, Duester G, Day BJ, Huang J, Hines LM, Vasiliou V. Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice. J Biol Chem 2007; 282(35):25668–25676.
   PubMed Web of Science ®Google Scholar
• Kirby TJ. Cataracts produced by triparanol (MER-29). Trans Am Ophthalmol Soc 1967; 65:494–543.
   PubMedGoogle Scholar
• MacDonald JS, Gerson RJ, Kornbrust DJ, Kloss MW, Prahalada S, Berry PH, Alberts AW, Bokelman DL. Preclinical evaluation of lovastatin. Am J Cardiol 1988; 62(15):16J–27J.
   PubMed Web of Science ®Google Scholar
• Gerson RJ, MacDonald JS, Alberts AW, Kornbrust DJ, Majka JA, Stubbs RJ, Bokelman DL. Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors. Am J Med 1989; 87(4A): 28S–38S.
   PubMed Web of Science ®Google Scholar
• Gerson RJ, MacDonald JS, Alberts AW, Chen J, Yudkovitz JB, Greenspan MD, Rubin LF, Bokelman DL. On the etiology of subcapsular lenticular opacities produced in dogs receiving HMG-CoA reductase inhibitors. Exp Eye Res 1990; 50(1):65–78.
   PubMed Web of Science ®Google Scholar
• Gerson RJ, Allen HL, Lankas GR, MacDonald JS, Alberts AW, Bokelman DL. The toxicity of a fluorinated-biphenyl HMG-CoA reductase inhibitor in beagle dogs. Fundam Appl Toxicol 1991; 16(2):320–329.
   PubMedGoogle Scholar
• Mosley ST, Kalinowski SS, Schafer BL, Tanaka RD. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens. J Lipid Res 1989; 30(9):1411–1420.
   PubMed Web of Science ®Google Scholar
• de Vries AC, Vermeer MA, Hendriks AL, Bloemendal H, Cohen LH. Biosynthetic capacity of the human lens upon aging. Exp Eye Res 1991; 53(4):519–524.
   PubMed Web of Science ®Google Scholar
• Aleo MD. Lenticular toxicity of systemic therapeutics in the rat: case studies and mechanism-based screening approaches. Toxicologist CD Official J Soc Toxicol 2008; 102(S-1).
   Google Scholar
• Heywood R, Gopinath C. Morphological assessment of visual dysfunction. Toxicol Pathol 1990; 18(1 pt 2):204–217.
   PubMed Web of Science ®Google Scholar
• Schiavo DM. The use of laboratory animals in toxicology: an ophthalmoscopic assessment. Toxicol Pathol 1990; 18(1 pt 2):222–223.
   PubMed Web of Science ®Google Scholar
• Rubin LF. Current methods of eye examination in vivo. In: Hockwin O, Green K, Rubin LF. eds; Manual of ototoxicity testing of drugs. New York: Gustav Fischer Verlag. 1992, pp. 81–108.
   Google Scholar
• Kuiper B, Boeve MH, Jansen T, Roelofs-van Emden ME, Thuring JW, Wijnands MV. Ophthalmologic examination in systemic toxicity studies: an overview. Lab Anim 1997; 31(2):177–183.
   PubMedGoogle Scholar
• Schiavo DM. The use of laboratory animals in toxicology: an ophthalmoscopic assessment. Toxicol Pathol 1990; 18: 222–223.
   PubMed Web of Science ®Google Scholar
• Guymer RH, Chiu AW, Lim L, Baird PN. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration? Surv Ophthalmol 2005; 50(2):194–206.
   PubMed Web of Science ®Google Scholar
• Thomas D, Duguid G. Optical coherence tomography—a review of the principles and contemporary uses in retinal investigation. Eye 2004; 18(6):561–570.
   PubMed Web of Science ®Google Scholar
• Schuman JS, Puliafito CA, Fujimoto JG. Optical Coherence Tomography of Ocular Diseases. 2nd ed; Thorofare, NJ: Slack. 2004; pp. 3–53.
   Google Scholar
• Grieve K, Paques M, Dubois A, Sahel J, Boccara C, Le Gargasson JF. Ocular tissue imaging using ultrahigh-resolution, full-field optical coherence tomography. Invest Ophthalmol Vis Sci 2004; 45(11):4126–4131.
   PubMed Web of Science ®Google Scholar
• Baltrukonis D, Fortner JH, Ryan AM, Somps CJ, Aleo MD, Verdugo ME. Comparisons between U18666A, naphthalene, and galactose on lens cholesterol biosynthesis and evaluation of cataract progression by Scheimpflug and slit lamp exams. Association for Research in Vision and Ophthalmology (ARVO), May 4–9, 2003 in Fort Lauderdale, FL, USA. 44ARVO E-Abstract 3489; 2003.
   Google Scholar
• Baltrukonis D, Fortner JH, Doshna CM, Render JA, Verdugo ME, Somps CJ. Evaluation of lens transparency using Scheimpflug photography and slit lamp biomicroscopy in the CJ-12,918 cataract model in the albino rat. Invest Ophthalmol Vis Sci 2004; 45(suppl 1, Apr):U171.
   Google Scholar
• Petrig BL, Riva CE, Hayreh SS. Laser Doppler flowmetry and optic nerve head blood flow. Am J Ophthalmol 1999; 127(4):413–425.
   PubMed Web of Science ®Google Scholar
• Harris A, Ciulla TA, Chung HS, Martin B. Regulation of retinal and optic nerve blood flow. Arch Ophthalmol 1998; 116(11):1491–1495.
   PubMed Web of Science ®Google Scholar
• Riva CE, Grunwald JE, Sinclair SH. Laser Doppler velocimetry study of the effect of pure oxygen breathing on retinal blood flow. Invest Ophthalmol Vis Sci 1983; 24(1):47–51.
   PubMed Web of Science ®Google Scholar
• Fishman GA, Birch DG, Holder GE, Brigell MG. Electrophysiologic Testing in Disorders of the Retina, Optic Nerve, and Visual Pathway. 2nd ed; New York: Oxford University Press. 2001.
   Google Scholar
• Narfstrom K, Ekesten B, Rosolen SG, Spiess BM, Percicot CL, Ofri R. Guidelines for clinical electroretinography in the dog. Doc Ophthalmol 2002; 105(2):83–92.
   PubMedGoogle Scholar
• Rosolen SG, Kolomiets B, Varela O, Picaud S. Retinal electrophysiology for toxicology studies: applications and limits of ERG in animals and ex vivo recordings. Exp Toxicol Pathol 2008; 60(1):17–32.
   PubMed Web of Science ®Google Scholar
• Bee WH. Standardized electroretinography in primates: a non-invasive preclinical tool for predicting ocular side effects in humans. Curr Opin Drug Discov Devel 2001; 4(1):81–91.
   PubMedGoogle Scholar
• Hockwin O, Green K, Rubin LF, eds. Manual of Ototoxicity Testing of Drugs. New York: Gustav Fischer Verlag. 1992: 109–413.
   Google Scholar
• Williams KK, Shepard AR, Rice RL, McCartney MD, Wax MB, Hiddemen JW. Corneal wound healing in New Zealand white rabbits following anterior keratectomy and treatment with moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3%. J Ocul Pharmacol Ther 2007; 23(6):517–525.
   PubMed Web of Science ®Google Scholar
• Viau S, Maire MA, Pasquis B, Gregoire S, Fourgeux C, Acar N, Bretillon L, Creuzot-Garcher CP, Joffre C. Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model. Graefes Arch Clin Exp Ophthalmol 2008; 246(6):857–867.
   PubMed Web of Science ®Google Scholar
• Barabino S, Chen W, Dana MR. Tear film and ocular surface tests in animal models of dry eye: uses and limitations. Exp Eye Res 2004; 79(5):613–621.
   PubMed Web of Science ®Google Scholar
• Xiong C, Chen D, Liu J, Liu B, Li N, Zhou Y, Liang X, Ma P, Ye C, Ge J, Wang Z. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride. Invest Ophthalmol Vis Sci 2008; 49(5):1850–1856.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gan L, Carlsson DJ, Fagerholm P, Lagali N, Watsky MA, Munger R, Hodge WG, Priest D, Griffith M. A simple, cross-linked collagen tissue substitute for corneal implantation. Invest Ophthalmol Vis Sci 2006; 47(5):1869–1875.
   PubMed Web of Science ®Google Scholar
• Kaps S, Richter M, Spiess BM. Corneal esthesiometry in the healthy horse. Vet Ophthalmol 2003; 6(2):151–155.
   PubMed Web of Science ®Google Scholar
• Ollivier FJ, Brooks DE, Komaromy AM, Kallberg ME, Andrew SE, Sapp HL, Sherwood MB, Dawson WW. Corneal thickness and endothelial cell density measured by non-contact specular microscopy and pachymetry in Rhesus macaques (Macaca mulatta) with laser-induced ocular hypertension. Exp Eye Res 2003; 76(6):671–677.
   PubMed Web of Science ®Google Scholar
• Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. Am J Ophthalmol 2005; 140(3):497–504.
   PubMed Web of Science ®Google Scholar
• Zhou X, Qu J, Xie R, Wang R, Jiang L, Zhao H, Wen J, Lu F. Normal development of refractive state and ocular dimensions in guinea pigs. Vision Res 2006; 46(18):2815–2823.
   PubMed Web of Science ®Google Scholar
• Fernandes A, Bradley DV, Tigges M, Tigges J, Herndon JG. Ocular measurements throughout the adult life span of rhesus monkeys. Invest Ophthalmol Vis Sci 2003; 44(6):2373–2380.
   PubMed Web of Science ®Google Scholar
• Kiuchi T, Tatsuzaki H, Hommura S, Oshika T. Specular microscopic study of X-ray-irradiated rabbit cornea. Eye 2004; 18(9):929–934.
   PubMed Web of Science ®Google Scholar
• Smith RS, Korb D, John SW. A goniolens for clinical monitoring of the mouse iridocorneal angle and optic nerve. Mol Vis 2002; 8:26–31.
   PubMed Web of Science ®Google Scholar
• Johnstone MA. The aqueous outflow system as a mechanical pump: evidence from examination of tissue and aqueous movement in human and non-human primates. J Glaucoma 2004; 13(5):421–438.
   PubMed Web of Science ®Google Scholar
• Gelatt KN, Mackay EO. Effect of different dose schedules of bimatoprost on intraocular pressure and pupil size in the glaucomatous beagle. J Ocul Pharmacol Ther 2002; 18(6):525–534.
   PubMed Web of Science ®Google Scholar
• Giuffrida S, Bucolo C, Drago F. Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma. J Ocul Pharmacol Ther 2003; 19(6):527–534.
   PubMed Web of Science ®Google Scholar
• Le Meur G, Weber M, Pereon Y, Mendes-Madeira A, Nivard D, Deschamps JY, Moullier P, Rolling F. Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates. Arch Ophthalmol 2005; 123(4):500–506.
   PubMed Web of Science ®Google Scholar
• Julien S, Kreppel F, Beck S, Heiduschka P, Brito V, Schnichels S, Kochanek S, Schraermeyer U. A reproducible and quantifiable model of choroidal neovascularization induced by VEGF A165 after subretinal adenoviral gene transfer in the rabbit. Mol Vis 2008; 14:1358–1372.
   PubMed Web of Science ®Google Scholar
• Weisse I. Microscopic examination of the eye. In: Hockwin O, Green K, Rubin LF, eds. Manual of Ocular Testing of Drugs. New York: Gustav Fischer Verlag. 1992; 137–163.
   Google Scholar
• Saunders LZ, Rubin LF. Ophthalmic Pathology of Animals. An Atlas and Reference Book. Basel, Germany: S. Karger. 1975; pp. 244–253.
   Google Scholar
• Latendresse JR, Warbrittion AR, Jonassen H. Creasy DM. Fixation of testes and eyes using a modified Davidson’s fluid: comparison with Bouin’s fluid and conventional Davidson’s fluid. Toxicol Pathol 2002; 30(4):524–533.
   PubMed Web of Science ®Google Scholar
• Saby JA, Sigler RE, Klaus S. Comparison of fixatives for histologic evaluation of the canine eye. J Histotechnol 1991; 14:251–255.
   Web of Science ®Google Scholar
• Smith RS, Zabaleta A, Simon WMJ, Bechtold LS, Ikeda S, Relyea MJ, Sundberg JP, Kao WW-Y, Liu C-Y. General and special histopathology. In: Smith R, ed. Systemic Evaluation of the Mouse Eye: Anatomy, Pathology, and Biomethods. New York: CRC Press. 2002:265–281.
   Google Scholar
• Smith RS, Nishina PM, Ikeda S, Jewett P, Zabaleta A, Simon WMJ. Interpretation of ocular pathology in genetically engineered and spontaneous mutant mice. In: eds. Ward JM, Mahler JF, Maronpot RR, Sundberg JP, Frederickson RM, Pathology of Genetically Engineered Mice. Ames, IA: Iowa Sate University Press. 2000:217–231.
   Google Scholar
• Michon JJ, Li ZL, Shioura N, Anderson RJ, Tso MO. A comparative study of methods of photoreceptor morphometry. Invest Ophthalmol Vis Sci 1991; 32(2):280–284.
   PubMed Web of Science ®Google Scholar
• Lee WR. ed. Ophthalmic Histopathology. 2nd ed; London, UK: Springer-Verlag. 2002; pp. 19.
   Google Scholar
• Millichamp NJ. Species specificity. Factors affecting the interpretation of species differences in toxic responses of ocular tissues. In: Chiou GCY. ed. Ophthalmic Toxicology. New York: Raven Press. 1992:59–82.
   Google Scholar
• Rubin LF. Comparative anatomy of the eye. In: eds. Hockwin O, Green K, Rubin LF. . Manual of Ocular Testing of Drugs. New York: Gustav Fischer Verlag. 1992:219–244.
   Google Scholar
• Taradach C, Greaves P. Spontaneous eye lesions in laboratory animals: incidence in relation to age. Crit Rev Toxicol 1984; 12(2):121–147.
   PubMed Web of Science ®Google Scholar
• Sinha DP, Cartwright ME, Johnson RC. Incidental mononuclear cell infiltrate in the uvea of cynomolgus monkeys. Toxicol Pathol 2006; 34(2):148–151.
   PubMed Web of Science ®Google Scholar
• Hubert MF, Gillet JP, Durand-Cavagna G. Spontaneous retinal changes in Sprague Dawley rats. Lab Anim Sci 1994; 44(6):561–567.
   PubMedGoogle Scholar
• Render JA, Carlton WW. Induced cataracts, lens, rat. In: eds. Jones TC, Mohr U, Hunt RD. Eye and Ear. New York: Springer-Verlag. 1991:63–73.
   Google Scholar
• Kiuchi K, Yoshizawa K, Shikata N, Matsumura M, Tsubura A. Nicotinamide prevents N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in Sprague-Dawley rats and C57BL mice. Exp Eye Res 2002; 74(3):383–392.
   PubMed Web of Science ®Google Scholar
• Tanito M, Kaidzu S, Anderson RE. Delayed loss of cone and remaining rod photoreceptor cells due to impairment of choroidal circulation after acute light exposure in rats. Invest Ophthalmol Vis Sci 2007; 48(4):1864–1872.
   PubMed Web of Science ®Google Scholar
• Sadun AA, Smith LE, Kenyon KR. Paraphenylenediamine: a new method for tracing human visual pathways. J Neuropathol Exp Neurol 1983; 42(2):200–206.
   PubMed Web of Science ®Google Scholar
• Mutsaers SE, Carroll WM. Focal accumulation of intra-axonal mitochondria in demyelination of the cat optic nerve. Acta Neuropathol 1998; 96(2):139–143.
   PubMed Web of Science ®Google Scholar
• Silva-Araujo A, Silva MC, Abreu-Dias P, Tavares MA. Effects of prenatal cocaine exposure in the retinal ganglion cell layer of the rat. A morphometric analysis. Mol Neurobiol 1995; 11(1–3):87–97.
   PubMed Web of Science ®Google Scholar
• Liu C-N, Simic D, Baltrukonis D, Doshna CM, Render JA, Fortner JH, Verdugo ME, Weisenburger WP, Somps CJ. Early MNU-induced retinal toxicity detected by electroretinography and visual acuity in funduscopically normal rats. Invest Ophthalmol Vis Sci 2004; 45(suppl 1, Apr): U341.
   Google Scholar